Background: Inflammation is implicated in causing diabetes. We tested
whether transcription factor 7 like-2 (TCF7L2) gene polymorphisms (rs12255372 and
rs7903146), consistently associated with type 2 diabetes, are associated with plasma
concentrations of inflammatory markers before and after three weeks of daily
treatment with fenofibrate... read more.
Keywords: Transcription factor 7 like-2, High sensitivity C-reactive
protein, Interleukin-2, Interleukin-6, Tumor necrosis factor-α, Macrophage
chemoattractant protein-1, Genetics of Lipid-Lowering Drugs and Diet
Kabagambe, Edmond, Stephen P. Glasser, Jose M. Ordovas,
Daruneewan Warodomwichit, Michael Y. Tsai, Paul N. Hopkins, Ingrid B. Borecki, Mary
Wojczynski, and Donna K. Arnett. "TCF7L2 polymorphisms and inflammatory markers
before and after treatment with fenofibrate." Diabetology & Metabolic Syndrome 1,
no. 1 (12, 2009): 1-4.